New drug could replace current standard for treating brain cancer
Glioblastoma (GBM) is a WHO grade IV brain tumor with dismal prognosis. Although post-surgical radiation…
January 20, 2023 - 3 minutes
radiotherapy
Actinium Pharmaceuticals and Columbia University to study Actimab-A in AML patients
Actinium Pharmaceuticals, Inc. has entered into a research collaboration with Columbia University to study Actimab-A,…
December 9, 2022 - 4 minutes
Startup Graegis developing therapies for radiation side-effects
Graegis Pharmaceuticals, a startup developing new therapies aimed at preventing the side effects of radiotherapies,…
December 6, 2022 - 2 minutes
New radiopharmaceutical shrinks prostate cancer tumors
Researchers in Japan and Germany say a radiopharmaceutical treatment targeting a prostate-specific membrane antigen effectively…
November 10, 2022 - 3 minutes
Study data for glioblastoma treatment confirms safety and tolerability profile
The final results of a phase 1/2 study of a therapy in recurrent glioblastoma multiforme…
September 22, 2022 - 4 minutes
